Web-Based End-of-Life and Post-Mortem Care Education for Nursing Students (NCT07737028) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Web-Based End-of-Life and Post-Mortem Care Education for Nursing Students
Turkey (Türkiye)74 participantsStarted 2027-02
Plain-language summary
This study aims to evaluate the effect of a web-based end-of-life and post-mortem care education program on nursing students' post-mortem self-efficacy, death literacy, and attitudes toward the principles of a dignified death. Participants will receive educational content through an online learning platform, and the effectiveness of the program will be assessed using validated questionnaires administered before and after the intervention. The findings are expected to support the development of accessible, sustainable, and effective digital education programs that enhance nursing students' knowledge, skills, and attitudes related to end-of-life and post-mortem care.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Fourth-year undergraduate nursing students enrolled at the Faculty of Health Sciences, Necmettin Erbakan University, during the 2026-2027 Spring semester.
* Successful completion of the Fundamentals of Nursing, Medical Nursing, and Psychiatric and Mental Health Nursing courses.
* Access to an internet-enabled device.
* Willingness to participate and provide informed consent.
Exclusion Criteria:
* Failure to complete at least one educational module.
* Failure to complete the baseline, post-intervention, or follow-up assessments.
* Withdrawal from the study at any time.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Post-Mortem Self-Efficacy
Timeframe: Baseline, immediately after completion of the 2-month intervention (approximately 2 months), and 2-month follow-up (approximately 4 months from baseline).